Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

3SBio Addresses Falling Share Price with Buyback

publication date: Mar 20, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

3SBio Inc. (NSDQ: SSRX) announced that it would begin a $20 million stock buyback. In February 2007, 3SBio made its IPO at a price of $16 per ADS, offering a total of 7.7 million ADSs to raise $123 million in gross proceeds. At the time of the buyback announcement, 3SBio’s closing quote was $7.60, a decrease of over 50% from the IPO price. In the year since its IPO, 3SBio has not reported any significant adverse news, but it hasn’t excited investors, either. More details... 

Stock Symbols: (NSDQ: SSRX) (NSDQ: AMGN) 




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners